| 1/4 | US=22 / Câncer Saif MW, Chu E. Antimetabolites. In: Devita Jr VT, Hellman S, Rosenberg AS. DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 427-37. MECANISMOS DE ACAO; MECANISMOS DE RESISTENCIA; FARMACOLOGIA CLINICA; TOXICIDADE |
| 2/4 | US=103 / Câncer Scaife J, Kerr D. Antimetabolites in cancer therapy. In: Missailidis S. Anticancer therapeutics. New Jersey: Wiley Blackwell, 2008. p. 91-110. ISBN 978-0-470-72303-6. CANCER. TERAPIA; ANTIMETABOLITOS; ANTAGONISTAS DE FOLATO; ANTAGONISTAS PIRIMIDINA; ANTAGONISTAS DE PURINA |
| 3/4 | US=92 / Biol/Mol Houghton JA. Established cancer therapies: antimetabolites. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 361-82. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. ANTIMETABOLITES; MORTE CELULAR; APOPTOSE; CATASTROFE MITOTICA; NECRESIS; SENESCENCIA |
| 4/4 | US=8 / Quimioterapia Hande KR. Purine antimetabolites. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 212-28. ISBN 978-0-7817-5628-6. ANTIMETABOLITOS PURINA; ANALOGOS GUANINA; ANALOGOS DA ADENOSINA; ALOPURINOL |